Tag: IMGC936
ImmunoGen to Prioritize Continued Development of Mirvetuximab Soravtansine
Waltham, Massachusetts, based ImmunoGen, expanding field of antibody-drug conjugates (ADCs) with the development of the next generation of targeted anti-cancer agents, has completed an...